Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NutriBand (NTRB) Cash & Equivalents (2018 - 2025)

NutriBand (NTRB) has disclosed Cash & Equivalents for 8 consecutive years, with $5.3 million as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents fell 6.77% to $5.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.3 million through Oct 2025, down 6.77% year-over-year, with the annual reading at $4.3 million for FY2025, 774.69% up from the prior year.
  • Cash & Equivalents hit $5.3 million in Q4 2025 for NutriBand, down from $7.0 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $8.3 million in Q2 2024 to a low of $151993.0 in Q1 2021.
  • Historically, Cash & Equivalents has averaged $3.5 million across 5 years, with a median of $3.2 million in 2022.
  • Biggest five-year swings in Cash & Equivalents: surged 3118.48% in 2022 and later plummeted 75.17% in 2024.
  • Year by year, Cash & Equivalents stood at $5.5 million in 2021, then crashed by 48.66% to $2.8 million in 2022, then tumbled by 55.07% to $1.3 million in 2023, then soared by 350.33% to $5.7 million in 2024, then decreased by 6.77% to $5.3 million in 2025.
  • Business Quant data shows Cash & Equivalents for NTRB at $5.3 million in Q4 2025, $7.0 million in Q3 2025, and $3.0 million in Q2 2025.